ONC.TO : Summary for ONCOLYTICS BIO - Yahoo Finance

U.S. Markets closed

Oncolytics Biotech Inc. (ONC.TO)


Toronto - Toronto Delayed Price. Currency in CAD
Add to watchlist
0.21-0.01 (-2.33%)
At close: 3:59 PM EST
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close0.22
Open0.20
Bid0.19 x
Ask0.21 x
Day's Range0.19 - 0.21
52 Week Range0.19 - 0.75
Volume390,970
Avg. Volume123,609
Market Cap25.44M
Beta2.89
PE Ratio (TTM)-1.86
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • CNW Group23 days ago

    Oncolytics Biotech® Inc. Announces Appointment of New Chief Medical Officer

    Oncolytics Biotech® Inc. Announces Appointment of New Chief Medical Officer

  • PR Newswire23 days ago

    Oncolytics Biotech® Inc. Announces Appointment of New Chief Medical Officer

    CALGARY, Nov. 10, 2016 /PRNewswire/ - Oncolytics Biotech® Inc. ("Oncolytics" or the "Company") (ONC.TO) (ONCYF) (ONY.F) today announced the appointment of Andres A. Gutierrez, MD, PhD to the role of Chief Medical Officer. "Dr. Gutierrez's significant immuno-oncology experience will be transformative to Oncolytics.  His expertise spans a range of indications and drug types that are immediately applicable to his new role and the clinical programs at Oncolytics," said Dr. Matt Coffey, Interim President and CEO of Oncolytics Biotech.

  • Associated Presslast month

    Oncolytics reports 3Q loss

    On a per-share basis, the Calgary, Alberta-based company said it had a loss of 2 cents. The company's shares closed at 21 cents. A year ago, they were trading at 35 cents. _____ This story was generated ...